Announcements and Notices - [Announcement by Offeree Company under the Takeovers Code / Matters relating to Options]

SciClone Pharmaceuticals (Holdings) Limited operates as a biopharmaceutical company. The Company develops produces and sells oncology drug, infectious diseases drugs and other products. SciClone Pharmaceuticals (Holdings) markets its products throughout China.

Sciclone Pharmaceuticals (6600 HK)

Announcement Pursuant To Rule 3.8 Of The Takeovers Code

Announcement Pursuant To Rule 3.8 Of The Takeovers Code

Announcement Pursuant To Rule 3.8 Of The Takeovers Code

Disclosure Of Dealings Under Rule 22 Of The Takeovers Code

Announcement Pursuant To Rule 3.8 Of The Takeovers Code